Discordance Analysis of VLDL-C and ApoB in UK Biobank and Framingham Study: A Prospective Observational Study
Arteriosclerosis, Thrombosis, and Vascular Biology · 2024-10 · 44 (10) · 2244-2251
DOI: 10.1161/atvbaha.124.321165 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2024-10. Verfasst von Selin Bilgic und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Mike and Valeria Rosenbloom Centre for Cardiovascular Prevention, McGill University Health Centre, Montreal, Quebec, Canada (…. Hauptthemen laut MEDLINE: Cholesterol, VLDL, Apolipoprotein B-100, Cholesterol, HDL, Biological Specimen Banks. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 48 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Recent observational and Mendelian randomization analyses have reported significant effects of VLDL-C (very-low density lipoprotein cholesterol) on risk that is independent of ApoB (apolipoprotein B). We aim to determine the independent association of VLDL-C and ApoB with the risk of new onset cardiovascular events in the UK Biobank and Framingham Heart Study cohorts. METHODS: We included 294 289 UK Biobank participants with a median age of 56 years, 42% men, and 2865 Framingham Heart Study participants (median age, 53 years; 47% men). The residual resulting from regressing VLDL-C on ApoB expresses the portion of VLDL-C not explained by ApoB, while the residual from regressing ApoB on VLDL-C expresses the portion of ApoB not explained by VLDL-C. Cox proportional hazards models for atherosclerotic cardiovascular disease incidence were created for residual VLDL-C and residual ApoB. Models were analyzed with and without high-density lipoprotein cholesterol (HDL-C). Furthermore, we investigated the independent effects of VLDL-C after accounting for ApoB and HDL-C and of HDL-C after accounting for ApoB and VLDL-C. RESULTS: In the UK Biobank, ApoB was highly correlated with VLDL-C (r=0.70; P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Mike and Valeria Rosenbloom Centre for Cardiovascular Prevention, McGill University Health Centre, Montreal, Quebec, Canada (S.B., K.M.P., J.C., L.D., G.T., A.D.S.).
- Brigham and Women's Hospital, Harvard Medical School, Boston, MA (K.M.P.).
- Duke University School of Medicine, Biostatistics and Bioinformatics, Duke Clinical Research Institute, Durham, NC (M.J.P.).
ORCID-Profile: Selin Bilgic, Michael J Pencina, Justine Cole, George Thanassoulis, Allan D Sniderman
Zitieren
APA
Bilgic, S., Pencina, K. M., Pencina, M. J., Cole, J., Dufresne, L., Thanassoulis, G., & Sniderman, A. D. (2024). Discordance Analysis of VLDL-C and ApoB in UK Biobank and Framingham Study: A Prospective Observational Study. Arteriosclerosis, Thrombosis, and Vascular Biology, 44(10), 2244-2251. https://doi.org/10.1161/atvbaha.124.321165
Vancouver
Bilgic S, Pencina KM, Pencina MJ, Cole J, Dufresne L, Thanassoulis G, et al. Discordance Analysis of VLDL-C and ApoB in UK Biobank and Framingham Study: A Prospective Observational Study. Arteriosclerosis, Thrombosis, and Vascular Biology. 2024;44(10):2244-2251. doi:10.1161/atvbaha.124.321165
BibTeX
@article{Bilgic2024,
author = {Bilgic, Selin and Pencina, Karol M and Pencina, Michael J and Cole, Justine and Dufresne, Line and Thanassoulis, George and Sniderman, Allan D},
title = {Discordance Analysis of VLDL-C and ApoB in UK Biobank and Framingham Study: A Prospective Observational Study},
journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
year = {2024},
volume = {44},
number = {10},
pages = {2244--2251},
doi = {10.1161/atvbaha.124.321165}
}
EUVIMED